Listing Top 5 Companies Transforming Neurological Disorder Diagnostics Market

The nervous system is complex. So, the evaluation and diagnosis of nervous system damage is a complicated affair. Several symptoms occur in different combinations among various disorders. Then there’s the challenge associated with several disorders not having definitive causes or tests. As such, there has been an increased focus on the development of innovative solutions. Let’s take a look at the essentials of neurological disorder diagnostics and the top neurological disorder diagnostics companies shaping the neurological disorder diagnostics market landscape.

Neurological Disorder: Overview

A neurological disorder is a condition affecting the functioning of the nervous system. It includes the peripheral nervous system and the central nervous system of the body. The brain and the spinal cord are part of the central nervous system. The peripheral nervous system has all the nerves that branch off to the spinal cord. It further breaks down into:

• Autonomic nervous system: Responsible for regulating activities that individuals do without thinking.
• Autonomic nervous system: It has the function of guiding voluntary movements.

The nervous system is responsible for regulating everything the individual does. It assists with breathing, swallowing, and sleeping. It coordinates senses and helps with processes such as digestion. Neurological disorders result in emotional, cognitive, or physical symptoms. They may result in pain, mood changes, or confusion.

Neurological Disorder Types

There are several neurological disorders. They can be separated into different categories. These include:

Neurodegenerative Conditions: These disorders result in the gradual degradation of neurons. Examples include Alzheimer's disease and Parkinson's disease.

Neuromuscular Conditions: These disorders affect the nerves and muscles. They impact the ability of the body to move. Amyotrophic lateral sclerosis and muscular dystrophy are neuromuscular conditions.

Brain Conditions: Brain conditions disrupt the normal functioning of the brain. They affect the emotional, physical, and cognitive well-being of the individual. These conditions take the form of migraines, epilepsy, and stroke.

Spine Conditions: Common spine conditions include herniated discs, scoliosis, and degenerative disc disease. These conditions may be due to age or injury. Other diseases may also cause them.

Neurological Disorder Diagnostic Tests

CT Scan: This imaging test makes use of computer technology and X-ray for creating detailed images of body parts. Images provided by scanners from the CT scanner market are more detailed than that of general X-rays. They are used to diagnose disorders of the brain, spine, and other parts of the nervous system.

Electroencephalogram (EEG): EEG involves placing electrodes on the scalp. These electrodes continuously record the electrical activity of the brain.

MRI: MRI tests use a combination of radio waves, large magnets, and computers to make detailed images of body structures and organs. A notable thing about MRI tests is that they don’t use ionizing radiation.

Positron Emission Tomography (PET): A small radioactive material, a computer, and a camera are used here. PET is used to assess how well tissues and organs are functioning. This test can detect the early onset of diseases than imaging tests.

Electrodiagnostic Tests: MRI solutions from the magnetic resonance imaging market are used for evaluating and diagnosing the disorders of motor neurons and muscles. They involve the insertion of electrodes into the muscle. The electrodes may also be placed on the skin overlying a muscle.  

Leading Neurological Disorders Diagnostic Companies

Koninklijke Philips N.S

Koninklijke Philips N.S. offers various diagnostic solutions for the neurological disorder diagnostics market. It does so through its advanced MRI, CT, and image-guided systems. Its MRI systems, including the Ingenia and MR 7700 series, are designed for high-quality neuroimaging. Its CT scanners include the Spectral CT 7500 and AI-enabled CT 5300. They are used for rapid assessment of acute neurological conditions such as stroke and hemorrhages. Its IntelliSpace Portal offers various advanced visualization and analysis tools for neurology.

In February 2024, Philips partnered with SyntheticMR for the development of a new software solution, Smart Quant Neuro 3D. The company stated the software solution is based on AI and is created for quantitative brain imaging to improve decision support.

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific offers research tools and diagnostic solutions for the neurological disorder diagnostics market. Its solutions are used for biomarker detection assays, advanced genetic sequencing diagnostics, and clinical trial support services. The company also offers immunoassays to quantify key biomarkers in cerebrospinal fluid (CSF) and plasma.

In September 2025, Thermo Fisher Scientific introduced the Olink Target 48 Neurodegeneration panel. It’s a part of the Olink Target 48 portfolio and is aimed at accelerating research into neurodegenerative diseases.

Canon Medical Systems Corporation

Canon offers various diagnostic equipment and software solutions to diagnose and treat neurological disorders. Stroke is a major focus area for Canon. The company offers automation platforms, CT brain prefusion, and MRI neuro packages to enable rapid detection and analysis. Its Alphenix interventional suites feature high-definition panel detectors for visualization of vessel anatomy. The company makes use of features like superb micro-vascular imaging (SMI) to evaluate cervical vessels in a non-invasive way.

FUJIFILM Holdings Corporation

FUJIFILM is involved in the diagnosis of neurological disorders through its medical imaging systems and AI-powered analysis software. It also supplies research-use antibodies and assay kits for neuroscience studies. Its AI solution makes use of 3D MRI brain images and clinical data to predict if a patient with mild cognitive impairment (MCI) will progress to Alzheimer's disease (AD) within two years. This makes it helpful in the Alzheimer’s therapeutics market. Its Synapse 3D system is used for brain perfusion analysis and tensor analysis.

QIAGEN

QIAGEN operates in the neurological disorder diagnostics field through advanced infectious disease testing and new precision medicine tools. Its multiplex PCR panel on the QIAstat-Dx automated system is capable of detecting nine common pathogens directly from a CSF sample. QIAGEN also has a strategic partnership with Neuron23. The partnership is focused on the development of the first next-generation sequencing (NGS) companion diagnostic for a neurodegenerative disorder.

Conclusion

Neurological disorders affect the normal functioning of the nervous system. There are hundreds of neurological disorders. Effectively diagnosing these conditions requires the use of advanced tools and skilled expertise. The key companies in the neurological disorder diagnostics market are expected to focus on strategic partnerships and innovations to offer advanced diagnostic solutions.